Stem cell therapy for human neurodegenerative disorders-how to make it work

Article Abstract:

The scientific basis of stem cell therapies is reviewed and their prospects in Parkinson's disease, stroke, amyotrophic lateral sclerosis (ALS) and Huntington's disease are discussed. However, it is argued that long-term survival of new, functionally integrated neurons is the main goal to achieve maximum symptomatic relief through stem cell therapy.

Science & research, Research, Usage, Stem cells, Neurodegenerative diseases

---

A channel to neurodegeneration

Article Abstract:

A potassium channel is used to study the death of neurons in specific regions of brain of the people suffering from the Parkinson disease. The study reveals that various drugs used in the treatment of the disease may decrease such risks, especially for the less severely infected individuals.

Diagnosis, Risk factors

---

Parkinson disease gene therapy moves toward the clinic

Article Abstract:

This article examines current therapies for Parkinson's disease and the development of gene therapy. The authors maintain current treatments for Parkinson's disease provide symptomatic relief, but the progress of gene therapy can stop or reverse the process of the disease.

Physiological aspects, Gene therapy

Similar abstracts:

• Abstracts: Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus
• Abstracts: Glucocorticoid therapy for chronic obstructive pulmonary disease. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
• Abstracts: Between hope and a hard place. Public funding for Alzheimer disease research in the United States. NIH gives money for orphan development

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.